Additionally, BAFF expression is highly upregulated in several subtypes of non-Hodgkin lymphoma (NHL), with increased BAFF serum levels correlating with more aggressive disease and worse outcome (10–12). The gene discussed is TNFSF13B; the disease is non-Hodgkin lymphoma.